耐用型左心室辅助装置作为移植桥接:新旧世界对比
本文综述美国与欧洲在心脏移植供体分配政策与器官可获得性上的差异,重点比较耐用型左心室辅助装置作为移植桥接(BTT)的使用现状。欧洲BTT用LVAD持续增加,而美国2018年UNOS政策修订后BTT用LVAD显著减少。作者建议美国分配政策可考虑支持天数、年龄与并发症类型以潜在提高植入率。
要点
- 欧洲BTT用LVAD持续增加,美国2018年UNOS政策修订后显著减少。
- LVAD技术改进改善短期和长期结局,支持其用于BTT适应证。
- 全球LVAD用于BTT的差异主要源于器官可获得性、分配政策与财务限制。
核心结论
- 心脏移植仍是终末期心衰无禁忌患者金标准,供体有限与等待时间长使LVAD作为BTT用于合适选择患者。
- LVAD技术改进改善短期和长期结局,进一步支持BTT适应证使用。
- 欧洲BTT用LVAD持续增加,美国UNOS 2018年政策修订后BTT用LVAD显著减少。
- 作者认为修改美国分配政策考虑支持天数、年龄与并发症类型可能必要,以潜在提高植入率。
研究设计与样本
- 综述,比较美国与欧洲心脏移植现状,聚焦不同分配政策与器官可获得性对医疗实践的影响。
- 回顾范围涵盖患者选择、植入前优化至移植后结局等关键方面。
主要发现
- LVAD用于BTT在全球呈现显著差异,主要因器官可获得性、分配政策与财务限制不同。
- 欧洲BTT用LVAD持续增加,美国UNOS 2018年政策修订后BTT用LVAD数量显著减少。
临床怎么用
- 作者认为美国分配政策可考虑支持天数、年龄与并发症类型以潜在提高植入率。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Heart transplantation remains the gold standard treatment for end-stage heart failure patients without contraindications. However, limited donor availability and long wait times have created a need for left ventricular assist devices (LVAD) to be used as a bridge to transplantation in appropriately selected patients. Improvements in LVAD technology have resulted in improved short- and long-term outcomes, further supporting the use of these devices for a bridge-to-transplant (BTT) indication. LVAD utilization as BTT exhibits notable disparities worldwide, mainly due to variations in organ availability, allocation policies, and financial constraints. Although Europe has experienced a consistent increase in the use of LVAD for this purpose, the United Network for Organ Sharing 2018 policy amendment resulted in a significant reduction in the number of LVADs used for BTT in the US. To overcome this issue, modifications in the US allocation policy to consider factors such as days on device support, age, and type of complications may be necessary to potentially increase implantation rates.The authors provide an overview comparing the current state of heart transplantation in the US and Europe, with a particular focus on how distinct allocation policies and organ availability impact medical practices. Additionally, the review will examine critical aspects ranging from patient selection and pre-implantation optimization to post-transplant outcomes.
引用
- Fernandez Valledor A, Rubinstein G, Moeller CM, et al. "Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World". J Heart Lung Transplant. 2024. PMID: 38360159. doi:10.1016/j.healun.2024.01.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。